227 related articles for article (PubMed ID: 6203301)
1. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Göransson AM; Kolari PJ; Mustakallio KK
Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
[TBL] [Abstract][Full Text] [Related]
2. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
Göransson A
Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
[TBL] [Abstract][Full Text] [Related]
3. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
Brandt H; Mustakallio KK
Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
[TBL] [Abstract][Full Text] [Related]
4. Irritation and staining by dithranol (anthralin) and related compounds. IV. Visual estimation of erythema compared with contact thermometry and laser Doppler flowmetry.
Mustakallio KK; Kolari PJ
Acta Derm Venereol; 1983; 63(6):513-8. PubMed ID: 6198841
[TBL] [Abstract][Full Text] [Related]
5. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
Mustakallio KK; Brandt H
Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
[TBL] [Abstract][Full Text] [Related]
6. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Remitz A
Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
[TBL] [Abstract][Full Text] [Related]
7. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
Brandt H
Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
Göransson A
Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
[TBL] [Abstract][Full Text] [Related]
9. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
Mustakallio KK
Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030
[TBL] [Abstract][Full Text] [Related]
10. Irritation and staining by dithranol (anthralin) and related compounds: I. Estimation with chamber testing and contact thermography.
Mustakallio KK
Acta Derm Venereol Suppl (Stockh); 1979; 59(85):125-32. PubMed ID: 294088
[TBL] [Abstract][Full Text] [Related]
11. Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
Greaves MW
Int J Clin Pharmacol Res; 1986; 6(4):315-6. PubMed ID: 2428761
[TBL] [Abstract][Full Text] [Related]
12. [Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
Puschmann M
Z Hautkr; 1983 Nov; 58(22):1646-7. PubMed ID: 6659639
[TBL] [Abstract][Full Text] [Related]
13. ["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients].
Runne U; Kunze J
Hautarzt; 1985 Jan; 36(1):40-6. PubMed ID: 3972578
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of dithranol erythema by the addition of tar in short-term therapy].
Wozel G; Barth J
Dermatol Monatsschr; 1985; 171(12):818-9. PubMed ID: 4092792
[No Abstract] [Full Text] [Related]
15. [Potential factors influencing dithranol erythema].
Richter G; Barth J
Dermatol Monatsschr; 1986; 172(5):272-5. PubMed ID: 3721033
[No Abstract] [Full Text] [Related]
16. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
[TBL] [Abstract][Full Text] [Related]
17. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
18. [Side effects of anthralin and its 2 main impurities on healthy skin].
Puschmann M; Schmersahl P
Z Hautkr; 1983 Mar; 58(6):410-6. PubMed ID: 6857758
[TBL] [Abstract][Full Text] [Related]
19. Treatment of psoriasis with dithranol cream compared with dithranol paste.
Young E
Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
[TBL] [Abstract][Full Text] [Related]
20. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses.
Brun P; Juhlin L; Schalla W
Acta Derm Venereol; 1984; 64(2):174-7. PubMed ID: 6203312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
